Connecticut Pharmacists Association (CPA) and CPA-PAC work aggressively to protect pharmacist’s interests, practice, and patients. As such, a number of issues take priority for the promotion and preservation of pharmacy. The Association’s annual legislative priorities are listed below.
2020 Legislative Testimony
Testimony regarding HB 5044 An Act Concerning Immunizations
Testimony regarding HB 5175/SB 1 An Act Concerning Diabetes and High Deductible Health Plans
Testimony regarding SB 125 An Act Concerning Department of Consumer Protection Licensing and Enforcement
Testimony regarding SB 135 An Act Concerning Revision of Pharmacy and Drug Control Statutes
Testimony regarding HB 5174 An Act Concerning Anti-Trust Issues and the Palliative Use of Marijuana
Please note that you must be logged into the CPA website as a member to view most of the resources below.
Pharmacy Benefit Manager (PBM) Transparency: Educate policymakers on healthcare reimbursement and work to facilitate fair business environments by promoting legislation that addresses issues such as prescription drug pricing and reimbursement, fair audit practices, mandatory-mail order programs and PBM transparency.
Opioid Epidemic: Work with stakeholders to create and pass public health policy, including the utilization and reporting methods implemented to decrease diversion and keep patients safe, while also maintaining access to medications for appropriate use.
Medical and Recreational Marijuana: As an organization that offers a public health benefit and addresses specific patient needs, CPA opposes the legalization of recreational marijuana in Connecticut. However, we also realize that recreational marijuana may nonetheless become a reality, and if/when that trend progresses, we will work closely and aggressively with the new administration and other stakeholders to craft responsible legislation that protects patients.
Immunizations: Work with stakeholders to ensure that patients have access to immunizations. Additionally, educate policy makers on the importance of pharmacists to provide accessibility to vaccinations in the community.
Medication Safety: Educate policymakers on the importance of promoting and supporting a culture of safety while emphasizing the potential negative impacts to healthcare that occur when medication errors are not reported due to a punitive environment.
Emergency Preparedness: Work with stakeholder groups to ensure that qualified individuals have the ability to participate in protecting communities during unforeseen events and are afforded the same professional immunity as other emergency responders. Ensure that pharmacies have the ability to operate, provide care and acquire medications through the proper channels during emergencies.